Secukinumab provides sustained improvements in clinical and imaging outcomes in patients with psoriatic arthritis and axial manifestations: results from the MAXIMISE trial
Huvudupphovsmän: | , , , , , , , , , , , |
---|---|
Materialtyp: | Conference item |
Språk: | English |
Publicerad: |
Oxford University Press
2021
|